Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: DR. BOND who wrote (2184)	2/1/1998 4:06:00 AM
From: Craig Markell	Read Replies (1) \| Respond to of 7041

Barrons Article For those that don't have access to Barrons, the article referenced is titled "Not Just Seeking The Next Microsoft - Value approach in small-cap fund a winner". Excerpt: Another loser that he still has hopes for: Zonagen, whose principal claim to fame is developing a drug -- Vasomax -- for "male erectile dysfunction." Although investors are nervous about the efficacy of the drug, McCrickard is cheered by Schering-Plough's decision to make a major investment in the project.